Dr. Dan Gincel
Position: Executive Board Member
Dr. Gil Blander
Position: Founder & Executive Board Member
Dr. Shmulik Hess
Position: Founder & Chairman of the Executive Board
Dr. Hess received his PhD in Pharmaceutical Science from the Hebrew University, Israel and was a research fellow at Harvard-MIT Health Sciences and Technology (HST) Dr. Hess has gained numerous patents and publications in peer reviewed scientific journals. Prior to joining Enlivex Dr. Hess served as the CEO of Valin Technologies since inception overseeing the execution of the company activities and its achievements including the development and technology transfer of several biosimilars and the in-licensing and acquisition of three early stage innovative projects and the further drug development process. Prior to joining Valin Technologies Dr. Hess was founder and CEO of ActivePx, a biotech company engaged in the development of oral available peptides for the treatment of pain. Following which he served as associate global operations at Scigen LTD (NASDAQ: VBIV), where he supported the establishment of a state of the art vaccine manufacturing facility for SciBvac® as well as a biologic manufacturing facility in India. Dr. Hess is co-founder and chairman of ScienceAbroad an NGO dedicated to encouraging and support the return Israeli scientist from abroad. Dr. Hess has experience with drug development, process development and scale-up of biologics and GMP manufacturing.
Mr. Sagi Balasha
Position: Executive Board Member
In October 2015, Sagi and his family returned to Israel. Today Sagi is business development and project management consultant for an array of organizations. His major focus is on the development of Israel-based projects in the cyber field and fighting the de-legitimization and hatred campaign against Israel, in collaboration with a number of American philanthropists and organizations. Sagi is also the current CEO of the Israel Free Loan Association (IFLA).
Prior to his position at the IAC, Sagi was the VP of Finance and Development at Beit Hatfutsot (2006-2011) where he headed a financial recovery plan that served to restore and renew the organization from a state of major deficit – increasing the museum’s budget, space and number of visitors by more than 100%. Prior to this (2001-2006), Sagi was the Department Manager and later Department Director of Israel’s Ministry of Finance Budgets Department, where he oversaw 20% of the government’s budget and was involved in major structural changes and reforms.
Sagi has a BA with Honors in Economics and Geography from Ben-Gurion University of the Negev and earned his MA at The Hebrew University of Jerusalem.
Prof. Shulamit kazav
Position: Executive Board Member
Prof. Shulamit Katzav is the Bernard L. and Mary T. Sachs Professor of Cancer Studies. She earned her PhD at the Weizmann Institute of Science and undertook her post-doctoral research at the National Cancer Institute in Frederick, MD. Shulamit was a visiting scientist at St. Jude Children’s Research Hospital in Memphis, Tennessee and an Associate Professor at McGill University in Montreal, Canada. Since 1995, Shulamit has been a member of the Institute of Medical Research Israel-Canada (IMRIC) at The Hebrew University of Jerusalem, Israel.
Shulamit served as the Chairs of the Research Committee of the Faculty of Medicine, Search Committee for the recruitment of young academic members (“Vaadat Sinun”), and the Department of Development Biology and Cancer Research at the Faculty of Medicine, Hebrew University. She is currently charged with implementing a bold and innovative new curriculum at the Hebrew University Medical School.
Shulamit’s lab focuses on the link between signal transduction and cancer, investigating a signal transducer protein, Vav, which is involved in coupling extracellular events to alterations in gene expression in the hematopoietic system. Shulamit discovered Vav when she tested DNA from five esophageal carcinomas for transforming activity. This newly identified gene represented the sixth transforming gene (oncogene) detected in the laboratory and it was designated Vav, the sixth letter of the Hebrew alphabet. She was recently the first scientist to demonstrate that Vav plays a major role as an oncogene in human cancers such as neuroblastoma, breast and lung. Vav was also shown to be integral to the development of pancreatic cancer. This indicates that Vav can be a promising target protein in anti-tumor therapy.
Prof. Rivka Carmi
Professor Rivka Carmi was elected to serve as President of Ben-Gurion University of the Negev (BGU) by the University’s Board of Governors in May, 2006. She is the first woman to serve as president of an Israeli university.
Rivka was born in Israel and is a graduate of the Hadassah Medical School at the Hebrew University of Jerusalem. She completed a residency in pediatrics, a fellowship in neonatology at the Soroka University Medical Center and an additional two-year fellowship in medical genetics at Boston Children’s Hospital and Harvard University Medical School.
Rivka served as Director of the Genetics Institute at the Soroka University Medical Center and held several important academic administrative positions in the Faculty of Health Sciences at Ben-Gurion University of the Negev. Promoted to full professor in 1995, she is the incumbent of the Kreitman Foundation Chair in Pediatric Genetics. In 2000, she was elected Dean of the Faculty of Health Sciences at BGU – also the first woman to hold this position in Israel – and served in that position for five years. In 2002 – 2005, she served as the Chair of the Israeli Association of Medical Deans.
Prior to entering the University’s administrative arena, Rivka’s research focused mainly on the delineation of the clinical manifestations and molecular basis of genetic diseases in the Negev Arab-Bedouin population. Author of over 150 publications in medical genetics, her research includes the Identification of 12 new genes and the delineation of 3 new syndromes, one of which is known as the Carmi Syndrome. Her community projects were aimed at preventing hereditary diseases in the Bedouin community. She was deeply involved with the establishment of major biotechnology initiatives at Ben-Gurion University of the Negev, primarily serving as the Acting Director of the nascent National Institute for Biotechnology in the Negev.
In addition to her duties as President, Rivka remains a member and serves as a consultant of national, professional and public committees and organizations, is a scientific reviewer for various international journals and funding agencies and serves on the editorial board of prestigious scientific journals. Recent noteworthy honors she has received include: the Lifetime Achievement Award by the Yated organization for children with Downs Syndrome; the Achievement in Medicine Award by the Municipality of Beer Sheva; the 2002 Award for Peace from the Canada International Scientific Exchange Program (CISEPO), to which she served as representative of the Israeli Medical Deans; the 2008 Women of Distinction Award of the Hadassah Women’s Zionist Organization of America; and in 2009, an Award of Excellence from the Israel Ambulatory Pediatric Association (IAPA). In 2013 she received an Honorary Doctorate from Dalhousie University in Halifax, Nova Scotia.
In August 2010, Rivka became the first woman to serve as the Chair of the Committee of University Heads in Israel. She served in this role until December 2012.
In June 2015, Rivka received an honorary Commander of the British Empire (CBE) in the name of Queen Elizabeth II
Prof. Rachel Erhard
Prof. Manuel Trajtenberg
In 2006, Manuel set up the National Economic Council in the Prime Minister’s Office, which he headed until 2009. Between 2009 and 2014, Manuel chaired the Planning and Budgets Committee in the Council for Higher Education. Following the social protests in 2011, he was appointed Chair of the Government Committee for Social and Economic Change (the Trajtenberg Committee), spearheading, inter alia, extension of the Free Education Law to kindergarten-aged children. He was also a member of several public committees, including the Brodet Committee for the Defense Budget and the Shochat Government Committee for the Reform of Higher Education. He was also a member of the Israel Democracy Institute Executive Committee and the Scientific Advisory Board at RAFAEL during development of the Iron Dome defense system. He also served as economic advisor to ministers and chief scientists in the Ministry of Industry, Trade and Labor.
Manuel was elected to his maiden term in parliament for the 20th Knesset as member of the Zionist Camp. He serves as member of the Finance Committee; Education, Culture and Sports Committee; the Joint Committee for the Defense Budget and the Special Committee to Discuss the Motion for the Agenda on Difficulties in Reforming the Civil Service. He also chairs the Lobby for the Protection of Preschoolers in Israel; the Lobby for Growth Companies in Israel and the Lobby for the Creation of Opportunities for the Haredi Public in Israel. He is a member of the Lobby for Children and Youth at Risk; the Lobby for Development of the Arab Economy; the Lobby for Strengthening the Jewish World; the Lobby for Rare Diseases and Orphan Diseases; the Lobby for Fair Pension; the Lobby for Young Families; the Lobby for Jewish Renewal and Lobby for Narrowing Gaps in Education. He also chairs the Israel-Peru and Israel-Cyprus Parliamentary Friendship Groups.
Prof. Gadi Schuster
He earned his bachelor’s degree (summa cum laude) from the Hebrew University of Jerusalem in 1982, and then continued for a PhD, obtained in 1988 from the same university. Gadi spent three years as a post-doctoral fellow at Berkeley, CA and then joined the Technion as an Assistant Professor in 1992. He served as the Executive Vice President for Academic Affairs of the Technion from 2012-2015, Dean of the Faculty of Biology from 2008-2012 and Vice Dean of the Jacobs Graduate School at the Technion from 2005-2008.
Gadi received several honors and prizes, including the best lecturer award twice. He served on numerous professional committees and is a frequent presenter at conferences and workshops. He is married to Dr. Ayelet Schuster, an ecologist, has two children, Meromit and Tal, and two grandchildren.
Prof. Dov Reichman
He is the owner and CEO of Spectra-Analytics, which consults companies, investors, and entrepreneurs in the areas of technological innovation, and traditional industry, services, and investments.
He was formerly CEO in chemical and diagnostics companies, VP of commercialization of technologies and patents in applied chemistry and physics at The Hebrew University of Jerusalem, and Marketing and Sales Manager in the multi-national Sigma Aldrich Company (NASDAQ: SIAL).
Dov’s technological expertise is in the fields of chemistry, advanced materials, nanotechnology, green industries, and security technologies. Dov has a PhD in chemistry from The Hebrew University in Jerusalem and his research earned the Israeli President’s Award for two consecutive years.
Dr. Natalie Artzi
She completed her postdoctoral studies Prof. Elazer Edelman’s lab at MIT, focusing on smart biomaterials design.
Natalie pioneered basic research in the areas of tissue adhesive materials and tissue: material interactions. She completed her PhD under the mentorship of Prof. Moshe Narkis at the Department of Chemical Engineering at the Technion, Israel Institute of Technology. Her PhD focused on the development of Polymers: Clay Nanocomposite Systems.
Natalie directs multiple research venues aiming to integrate science, engineering and medicine to solve problems in human health. Her tissue-responsive nanomaterials research is dedicated to rationally designing personalized materials and medical devices to combat cancer, improve tissue regeneration in orthopedic applications and treat gastrointestinal diseases.
She was a member of the Scientific Advisory Board of Science Translational Medicine, the Program Committee of the American Society for Biomaterials, as well as editorial boards and advisory boards of biotech companies. Aiming to propel technologies from bench to bedside, the group studies tissue: biomaterial interactions in light of clinically-relevant conditions as manifest by the disease. Natalie recently founded her first spin off company from her lab, which provides solutions for better wound closure and healing following internal surgeries.
Dr. Noam Shomron
Dr. Noam Shomron received his BA in Biotechnology from the Macquarie University in Sydney, Australia; his MA in Gene Therapy at The Hebrew University of Jerusalem; and a PhD in Genetics from Tel Aviv University where he worked on regulatory RNA systems. As a postdoctoral affiliate at MIT in Cambridge, USA, Noam specialized in combining high-throughput data with computational analysis to decipher gene regulation in health and diseases. Today, Noam heads the Functional Genomics Laboratory at Tel Aviv University’s Medical School, and serves as the Editor-in-Chief of Genetics Research, a Cambridge University Press Journal. Noam’s team explores regulation of gene expression mainly by small RNAs, and aspires to reach a global systems’ view of the mechanistic roles they play in health and diseases.
Dr. Amir Bahar
Dr. Amir Bahar is a graduate of the Weizmann Institute of Science and a veteran of Mount Sinai Medical Center in New York and the Technion.
Amir completed his PhD in neurobiology and brain research at the Weizmann Institute in 2004. His thesis focused on the biochemical and neurophysiological aspects of learning. He later completed a postdoc in neurophysiology of learning at the Mt Sinai Medical School, NY. In parallel, he served as BioAbroad’s regional manager. He returned to Israel in 2011 to pursue a career in the biomedical industry. In 2013 he co-founded a medical device company that develops smart nanofibers for the surgical field. The company has been active in the Chief-Scientist’s incubator in Nazareth since April 2014.
Dr. Sara Eyal
Her interest in drug research was roused during high school at youth science camps. Following her military service, she completed undergraduate studies at the Faculty of Agriculture at Tel Aviv University, continuing her MA at the Department of Physiology and Pharmacology at Tel Aviv University, under the tutelage of Prof. Moshe Rehavi. Upon completion, Sara began a pharmacy degree at the School of Pharmacy at The Hebrew University of Jerusalem and specialized in pharmaceuticals and internal medicine at Assaf Harofeh Medical Center. She then completed graduate studies in Clinical Pharmacy. Her MA research was guided by Professors Amnon Hoffman and Michael Friedman and focused on the development and characterization of a gastroretentive dosage form of levodopa. Sara received her degree Summa Cum Laude in 2002 and continued her studies in the laboratories of Professors Meir Bialer and Boris Yagen toward her PhD. Her work focused on the mechanisms of pharmacokinetic resistance to antiepileptic drugs, which occurs in about 30% of patients with epilepsy. One of its findings saw the antiepileptic drug, valproic acid, and some of its derivatives, increase the expression and activity of P-glycoprotein, an efflux transporter which removes drugs from cells, contributing to the pharmacokinetics of many drugs and to multidrug resistance in cancer cells. Results of her research were published in Epilepsia, the British Journal of Pharmacology and Biochemical Pharmacology.
Prof. Gad Barzilai
Gad Barzilai is a professor of law, political science and international studies, known for his work on the politics of law, comparative law and politics, human rights and communities.
Prof. Barzilai published 18 books, some of which are award-winning, and 173 articles in major academic journals and publishing houses. Over the course of his career, prof. Barzilai has been teaching at the University of Washington in the USA, and the Tel Aviv University. Prof. Barzilai served as the Dean of the Faculty of Law at the University of Haifa (2012 – 2017).
Prof. Barzilai is currently serving as a Vice-Provost and the Head of the International School at the University of Haifa.
Mrs. Malka Lion
Prof. Karen B. Avraham
hereditary hearing loss. Her team takes a comprehensive approach to studying the molecular basis of hearing loss, using genetic, developmental, biochemical, cellular and bioinformatic tools. She leads efforts in next-generation sequencing for the discovery of disease genes that are relevant for the Israeli Jewish and Palestinian Arab hearing impaired population. Her group has demonstrated that non-coding RNAs – microRNAs, are essential for the development and functioning of inner ear hair cells in vertebrae.
Dr. Neta Kela
Dr. Neta Kela, PhD, is a business development professional in the field of innovative technologies in the healthcare and biotechnology industries. Neta is the Co-Founder of CGA, an automated CAR-T manufacturing device company and the Founder and CEO of Omni, an international business development and scientific consulting firm specializing in precision medicine, cell therapy and immunomodulation. Neta graduated with a PhD from the Weizmann Institute, focusing on clinical research and auto-immune disorders. Following her PhD, Neta was a postdoc fellow at Stanford University, CA, USA, focusing on clinical oncology research and won the McCormick Award from Stanford University, School of Medicine. Neta is a senior faculty member at the Peres Academic Center for Innovation and Entrepreneurship and a lecturer at the Ben-Gurion MBA Executive Program
Dr. Dov Tamarkin, CEO
Dr. Iris Grossman
Dr. Iris Grossman, VP, Global Head of the Personalized & Predictive Medicine and Analytics Big Data (PPM-ABD) unit for Teva Global R&D, has dedicated her research career (industry and academia) to the advancement of personalized medicine. She is currently charged with defining and implementing the global PPM-ABD strategy for Teva R&D, a leading global pharmaceutical company, covering discovery development and repurposing programs. In 2013, Globes Magazine – Israel’s leading financial magazine, coined Dr. Grossman one of Israel’s top 40 professionals under the age of 40 .
Prior to joining Teva, Dr. Grossman was CEO and president of the pharmacogenetics management consultancy IsraGene Ltd., providing services to both the pharma and biotech sectors. This followed several years of spearheading pipeline pharmacogenetic programs for industry and academia as director of pharmacogenetics at Cabernet Pharmaceuticals Inc. Dr. Grossman moved into consultancy having been responsible for running large-scale pharmacogenetic programs at GlaxoSmithKline, with an emphasis on infectious and neurological diseases.
In academia, Dr. Grossman was a key member of Professor David Goldstein’s team at the Center for Population Genomics and Pharmacogenetics, Institute for Genome Sciences and Policy, at Duke University. Dr. Grossman received her PhD from the Technion – Israel Institute of Technology, where her research project, conducted in collaboration with the Weizmann Institute for Science, investigated pharmacogenetic markers of multiple sclerosis treatment response.
Prof. Jerry Eichler
Mr. Yoran Bar
A mission-oriented entrepreneur with track record performing senior executive roles in the Israeli High Technology scene.
Currently serving as CEO and Co-founder of BeaconCure, a startup with developing an AI text analytics technology for clinical data.
Yoran also serves as the founding Director of ‘The HAC’, a successful Urban Accelerator in Israel, where I serve as a member of the advisory board supporting the organization and its young entrepreneurs as a pro bono project.
Yoran also acts as Israel Country Adviser for the US-based ‘International Accelerator’ from Austin Texas and, as an International Adviser for ‘TechGrind’ an Asian Accelerator based in Bangkok, Thailand.
Yoran spent a few years in West Europe serving multinationals such as Adidas and HP in the development of data-centric systems while resided in Amsterdam, The Netherlands.
Yoran completed his MBA from the University of Den Haag and owns a BA in Psychology & Communications from the University of South Africa.
Mr. Mati Gill
Head of Government Affairs and Policy, Corporate HQ & Growth Markets Teva Pharmaceutical Industries Ltd.
Mati is the Head of Government Affairs and Policy for Corporate HQ and Growth Markets at Teva Pharmaceutical Industries, a global leader in generic and specialty pharmaceuticals that delivers high-quality medicines to 200 million people around the world every day. Mati previously served as Chief Operations Officer (COO) of the Teva Global Legal Group between 2011-2016 and serves as a member of the Board of Directors of Sanara Ventures.
He is also a licensed Lawyer and served as the Executive Director of the Australian Israel Leadership Forum. Until March 2009, Mati served as Chief of Staff of Israel’s Minister of Public Security Mr. Avi Dichter, a position in which he was in charge of management of the Minister’s public agenda and office, and advised on professional, political, communications and international affairs.
Mati is an active social entrepreneur in the Israeli community. He co-founded and leads the “Sanhedrin Forum” for young Israeli professionals. A reserve officer at the rank of Major in the IDF, Mati served as Operational Liaison Officer with United Nations Peacekeeping Forces in Lebanon and the Golan Heights and with the United States Army.
Prof. Shulamit Michaeli
Faculty of Life Sciences and Institute for Nanotechnology and Advanced Materials, Bar-Ilan University.
Prof. Shulamit Michaeli is a member of the Mina and Everard Goodman Faculty of Life Sciences and the Nano Medicine Center at the Institute of Nanotechnology and Advanced Materials (BINA). She is an expert on silencing RNA – designing and synthesizing RNA-protein complexes that inhibit the functioning of a variety of genes from human parasites to man.
Prof. Masha Niv
Prof. Masha Niv’s lab studies molecular recognition of taste and smell compounds using atomistic computational methods as well as sensory evaluation and in-vitro techniques. Masha graduated cum laude in Chemistry in 1994 and continued directly into PhD in theoretical chemistry, graduating in 2001 from the Hebrew University. She worked as a bioinformatician and group leader at Keryx Pharmaceutical before her postdoctoral position at the Weill Medical College of Cornell University, NY. Masha established her lab at the Robert H. Smith Faculty of Agriculture, Food and Environment at the Hebrew University, Rehovot, in 2007. Masha is passionate about promoting scientific careers for young scientists, and specifically women in science.
Dr. Nurit Eyal
Dr. Michal Zalzman
Dr. Michal Zalzman has been a molecular cell biologist and an established stem-cells expert since 2000. She received her BSc from the University of Bar Ilan, Israel, MSc and PhD from Tel Aviv University, Israel, in the Department of Human Molecular Genetics and Biochemistry. She then completed postdoctoral work at the National Institute of Aging/NIH, in the Developmental Genomics and Aging Section in the Laboratory of Genetics. She holds multiple worldwide patents from WIPO.
Michal’s lab focuses on novel fundamental mechanisms controlling cellular immortality. Her team studies cellular immortality and telomere repair in two major systems: adult stem cells and cancer cells. Their goal is to characterize the components of a novel apparatus that allow cancer to bypass cell aging in order to ultimately allow the development of a new class of agents designed to target cancer immortality. The lab has also generated adult stem cell lines from multiple tissue sources. The teams develops novel protocols to enhance the replicative lifespan and the differentiation potential of adult stem cells. This research will allow the large scale expansion of adult stem cells required for future therapies of numerous diseases that are currently candidates for stem cell treatment.
Prof. Roy Kishony
Visiting Faculty – Department of Systems Biology, Harvard Medical School.
Prof. Roy Kishony is the Marilyn and Henry Taub Professor of Life Sciences at the Technion-Israel Institute of Technology, Director of the Technion’s Lorry Lokey Center for Life Sciences and Engineering and a Visiting Faculty Member at the Department of Systems Biology at Harvard Medical School. Roy received his BA in Physics and Mathematics from The Hebrew University of Jerusalem and his PhD in Physics from Tel Aviv University (1999). He transferred to Biology in his postdoc at Princeton and Rockefeller Universities. In 2003, he started an independent laboratory at Harvard University, first as a Bauer Fellow and then as a member of the newly established Department of Systems Biology at the Harvard Medical School, where he was quickly promoted to a Full Professor. As a physicist at a major medical school, Roy became fascinated by the urgent public health concern over the rapid evolution of antibiotic resistance.
His combined theoretical-experimental background enabled him to define key questions in evolution of resistance in bold new ways. His lab has made a series of ground-breaking discoveries, showing how some drug interactions can select against resistance, unraveling mechanisms that keep resistance in check in natural ecological environments, and pioneered unique experimental and theoretical methodologies for tracking whole-genome evolution of pathogenic bacteria. These new approaches and discoveries inspire novel treatment paradigms for effective antimicrobial chemotherapy and genome-based diagnostics.
Roy received the Genzyme award for outstanding achievements in biomedical sciences (2009), a Gates Foundation Grand Challenge Award (2008), a Complex Systems award from the McDonnell Foundation (2008), the Sanofi-Pasteur award (2013) for “establishing the quantitative principles governing evolution of resistance in multi-drug treatments, creating a new discipline at the intersection of pharmacology, systems biology, and evolution”. He has been elected as a member of the Israeli Young Academy (2016), and as a member of EMBO (2017). His research has attracted significant attention, was featured at the United Nations and has been covered in the international media, including CNN, NPR, WIRED, Wall Street Journal, Boston Globe, Scientific American, Nature News, 60-Minutes Australia and the UK’s BBC.
Dr. Yaron Daniely
I am interested in the field of applied sustainable waste management. This field gives value to agriculture and food residues. I currently explore two related avenues: first, a sustainable pest management technique called biosolarization, and second, a waste-to-energy process through anaerobic digestion. In both of these projects, I utilize microbial communities as a work force platform. I use next generation sequencing along with advanced fermentation processes to elucidate the role of these microbial communities in complex bioengineered systems (“xeno-ecological” niches). In the biosolarization project, I conduct lab simulations of field soils and explore the fate of different waste residue amendments. In the anaerobic digestion project, I adapt microbial communities to extreme conditions of low water, high temperature, and high organic loading rates.
Hagai is an alumni of the Shraga Segal Department of Microbiology and Immunology at Ben-Gurion University, where he studied the links between cellular senescence, wound healing, and aging, under the mentorship of Prof. Vadim Fraifeld. Currently, he is a postdoctoral fellow at the National Institute on Aging (NIA), hard at work in the lab of Dr. Isabel Beerman, investigating the aging of hematopoietic stem cells.
Adi completed his B.Sc. degree at Ben-Gurion University, in the Marine Biology and Biotechnology program. He later received his M.Sc. from the Faculty of Agriculture Food and Environment at the Hebrew University, where he studied the effect of an alkaloid derivative on a model of Duchene Muscle Dystrophy using microarray technology.
For his Ph.D., Adi studied the interactions between marine sponges and their microbial symbionts, and graduated from the Zoology Department at Tel Aviv University.
In his current research, Adi is studying the microbial ecology of soils at a sub-alpine watershed, using genome-resolved metagenomics and metatranscriptomics. The goal of this study, which is part of a long-term research effort taken by the Department of Energy, is to model how early snowmelt, due to climate change, affects carbon and nitrogen dynamics in high altitude watersheds, and how this in turn affects downstream water sources.
Ray got his BSc Degree from Ben-Gurion University, in the Marine Biology and Biotechnology program. He was then accepted to the direct PhD program at Tel-Aviv University, where he did his research in Prof. Ilan’s sponge lab at the Zoology Department. His thesis work focused on sponge-associated microbes participating in the arsenic cycle, especially biomineralizing bacteria.
Ray is currently in UC Berkeley, doing his postdoc in two labs; Alvarez-Cohen group in Civil and Environmental Engineering and Banfield group in Earth and Planatery Sciences. He has several research projects with a main theme of bioremediation. Some revolve around nitrogen remediation of wastewater and others related to arsenic remediation of groundwater
Zohar is currently a post-doc at the Hung Lab at The Broad’s Institute of Department of Molecular Biology. She was a post-doc at Ilana Kolodkin-Gal’s Lab Weizmann Institute of Science studying TB.
She completed her Ph.D. at the Pilpel’s lab at the Weizmann Institute.
Lior did his undergraduate and PhD studies in Tel Aviv University under the supervision of Dr. Anat Herskovits, and moved to Boston, U.S. in November 2015 to join Dr. Wendy Garrett’s lab at Harvard School of Public Health. His research focuses on the effects of our diet on the metabolism of gut microbiota and its’ effects on our physiology and health, e.g. colorectal cancer incidences.
Dr. Lobel was born and raised in Tel Aviv, Israel. He and his wife, Yaara, share their home with 2 cats (Zion and Nachum). They previously reached a personal record by living with three cats, one dog and one rabbit in a two-bedroom apartment in Tel Aviv.
In his spare time, Dr. Lobel enjoys playing soccer and collecting Lego sets. He also enjoys playing computer games and traveling whenever his schedule permits.
Mati is doing his postdoc in Immunology at the California Institute of Technology in Dr. David Baltimore’s lab, investigating different aspects of chronic inflammation. He received his B.S and MSc in Biochemistry from the Hebrew University, and his PhD in Molecular Genetics and Molecular Cell Biology from the Weizmann Institute of Science.
Mati also served as a coordinator and lead instructor of basic biology for high school students at the Davidson Institute of Science Education, and is now volunteering in Science Education for high school students around Pasadena.
Taking advantage of all the great opportunities southern California has to offer, Mati enjoys trail running, biking and hiking.
Sasha obtained a B.A. with distinction in Medical Laboratory Science (Faculty of Biology) and a M.Sc. with distinction in Physiology (Faculty of Medicine) from the Technion, Israel. She carried out her Ph.D. in Biomaterials and Tissue Engineering at the Faculty of Biomedical Engineering, also at the Technion. Sasha joined the Engineering Department at the University of Cambridge as a post-doctoral research associate in December 2014, having obtained a Blavatnik Fellowship, followed by a Marie Curie Fellowship. Dr Berdichevski’s research interests concern with designing scaffolds for tissue engineering, with specific focus on the effect of biomaterial composition and 3-dimensional configuration on the performance of the engineered tissue. In her post-doctoral project she has focused on cell-based approaches to create capillary networks and bone within collagen scaffolds with tailored pore architecture.
Sasha is married to Michael, and has a 10-year-old son, Liam.
Galit is a postdoctoral research associate as a Blavatnik Fellowship, in the Engineering Department at the University of Cambridge, UK. She is working on the vascularization potential of magneto-active bone scaffolds based on interconnected networks of ferromagnetic fibres. Galit obtained her PhD, MSc and BSc in the Department of Materials Engineering, Ben-Gurion University, Israel. Her research in BGU had concern with the development of biodegradable metallic implants. Galit is married to Haguy, has a 6-year-old son, Itay and 5-year-old girl, Romy.
Benny graduated with an M.Sc. in Biotechnology from Bar Ilan University, working in Prof. Orit Shaul’s lab, where he focused on the Arabidopsis thaliana vacuolar metal/proton exchanger. Despite this thrilling topic, his M.Sc. work was published in a journal you will likely never read or subscribe to (unless you belong for some reason to the “plant science” community).
Benny graduated with a Ph.D. from the Hebrew University of Jerusalem in the Department of Biochemistry and Molecular Biology, Hadassah Medical School, where he worked in Prof. Hannah Rahamimoff’s lab. In his Ph.D., Benny was interested in immunosuppressive drugs, immunophilins, and functional expression of the Sodium-Calcium Exchanger (NCX) Isoforms. His current work investigates the transcriptional control of myelin formation in the nervous system.
When not chained to the lab, Benny spends his free time biking around Chicago.
Nurit is a research associate in the Allergy and Immunology division in Cincinnati Children’s Hospital Medical Center. Nurit received her PhD from Tel Aviv University, under the mentorship of Prof. Ronit Sagi-Eisenberg where she investigated the mechanisms governing mast cell degranulation.
In Cincinnati, Nurit’s research focuses on esophageal epithelial cells. Epithelial cells are uniquely positioned as the very first line of defense to recognize immune insults such as food antigens, proteolytic allergens and microorganisms. Nurit’s work is aimed at identifying the role of proteases and their inhibitors in the propagation of eosinophilic esophagitis (EoE), an esophageal allergic disorder. EoE is characterized by imbalance between proteases and their inhibitors in the epithelium. Loss of protease inhibitors unleashes an uncontrolled protease activity in the esophagus that results in impairment of the epithelial barrier. As a result food antigens can penetrate into the esophageal tissues and activate immune response.
Ella is a postdoctoral fellow in the department of Plant Sciences, at the University of California, Davis. Her main interest are secondary metabolites, and her current research focusses on the cross talk between plant secondary metabolites and hormones under biotic stress. She is supported by the Binational Agricultural Research and Development Fund fellowship.
Ella conducted her Ph.D. and B.Sc. in Tel Aviv University, at the Department of Plant Biology and Ecology of Plants. In her Ph.D. Ella focused on revealing the mechanism of action of the secondary metabolite breakdown product indole-3-carbinol.
Omri is an Assistant Adjunct Professor in the Mathematics Department at the University of California, Los Angeles. He received his PhD and MSc from the Computer Science Department at the Technion — Israel Institute of Technology and his BSc from the Computer Science and Mathematics departments at the same institute. His research interests include dynamical systems, partial differential equations and numerical simulation with applications in Computer Graphics, Geometry Processing and Non-linear Dynamics.
Leor completed his BSc in Bar Ilan University, Israel, where he studied the interplay between brain and behavior in the Brain Science program. He obtained his PhD in the Neuroscience department at the University of Texas at Austin where he studied the causal relationship between key brain regions to complex cognitive behavior such as decision-making. These days, Leor works as a postdoctoral research fellow at the National Institutes of Health, seeking to uncover the neural mechanisms governing our ability to selectively attend to one thing (such as the words you are currently reading) while ignoring others (such as the sensation of your shirt on your shoulders). Leor enjoys thinking about neurons, obsessing over aesthetics and cooking elaborate meals.
Marianna is an NIH Postdoctoral Visiting Fellow at the Predictive Toxicology and Screening Group, US National Toxicology Program Laboratory (NIH/NIEHS in North Carolina). Marianna began her academic research as an academic officer at the Israel Naval Medical Institute after she graduated a bachelor’s degree in natural science (Biology, Technion – IIT). During her military service in the Navy, she pursued a second bachelor’s degree in engineering (Biotechnology and Food Engineering, Technion – IIT) and was later involved in research at the Molecular Nutrition Laboratory at the Biotechnology and Food Engineering Department, Technion – IIT (PhD candidate), at the Human Iron Metabolism Section at the NIH/NICHD in Maryland (research assistant), at the Microfluidic Technologies Laboratory at the Mechanical Engineering Department, Technion – IIT (research scientist) and at the Cancer Biology and Cannabinoid Research Laboratory, Technion – IIT (postdoctoral researcher). Marianna is seeking to continue her academic career in toxicology, a field that has always fascinated her due to its overlapping with various disciplines such as biology, chemistry, pharmacology and medicine, and due to its great impact on both human health and the environment.
Dr. Stav Kemeny has been an Associate Research Scientist in Columbia University in New York, living in Manhattan for the last eight years, and loving it! She moved to the U.S. with her dog, leaving behind a big family back in Israel. She likes to host, bake and walk outdoors.
Dr. Kemeny received her PhD from the Technion and her B.Sc. from the University of Ben Gurion in the Negev. She works on molecular mechanisms controlling cell death in neurons and is committed to Science Education to the broader audience. Stav is passionate about encouraging collaborations of academia and industry, built on what is already distinctive about the academia; its impartiality and independence. She is very much into promoting her initiative ScienceAbroad (BioAbroad) CouchSurfing.
Liora is an Instructor at the Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai. Her research fields include endocrinology, in particular diabetes, obesity and thyroid hormones dysfunction. Dr. Katz completed her post-doctoral training at the Laboratory of Endocrinology and Receptor Biology, NIDDK, NIH. She holds a Ph.D. from the department of Endocrinology, Diabetes and Nutrition, Geneva University, Switzerland, an M.Sc. in biological chemistry and a B.Sc. degree in Biology from the Hebrew University of Jerusalem, Israel.
I am currently a Postdoctoral fellow at New York University Medical Center, Department of Medicine, in Dr. Adam Mor’s lab investigating signaling pathways that effect adhesion between T cells and antigen presenting cells. I have completed my B.S.c. in molecular, cellular and medical biology, from the University of Bar Ilan, and then completed my M.Sc. from Tel Aviv University, in the Department of Microbiology under the supervision of Dr. Shai Ashkenazi and Dr. Yael Yuhas, studying the influence of Rifampin on prostaglandin E2. I received my Ph.D. from Tel Aviv University, in the department of Human Molecular Genetics and Biochemistry under the supervision of Dr. Hagit Eldar Finkelman. My PhD project was to understand the distinct molecular and cellular functions of GSK-3 isozymes. Another project studied during my PhD training, which I am very proud of, was the discovery of a novel-signaling pathway linking GSK-3 with mTORC1/autophagy, implicating a new role for GSK-3 in cell growth and cancer.
I am a mother of two amazing kids, Bnaya (7.5 years old) and Gaya (3.5 years old) and the wife of a very supportive husband, Eli.
Dorit Farfara is a 4th-year postdoctoral trainee, hosted by Prof. Sidney Strickland laboratory at the Rockefeller University. Her research focuses on the contribution of the peripheral innate immune system to brain function through inflammation and vascular system. Dorit has extensive experience in the field of neurodegenerative and neuroinflammatory disorders. Her Ph.D. was conducted in Tel-Aviv University under the supervision of Dr. Dan Frenkel and Dr. Ronit Pinkas-Kramarsky. She investigated the role of the resident immune cells, microglia, in Alzheimer’s disease. Dorit joined ScienceAbroad in 2016 and has been a regional manager in the Tri-institutional academy (The Rockefeller University, Weill Cornell, and MSKCC). Dorit goes by the phrase: “He who has a why to live can bear almost any how”.
Anna is a postdoctoral fellow in Cantley and de Wet labs in the Department of Physiology, Anatomy and Genetics, University of Oxford. She is working on metabolic homeostasis in diabetes and funded by the Novo Nordisk fellowship. Anna obtained her PhD from Weizmann Institute (Walker lab), her MSc from BGU (Sharoni and Levy lab) and BA from the Biology department, Technion. She is interested in the interplay between nutrition and metabolic signalling. Anna enjoys living in Oxford – the place that makes Harry Potter look like a documentary.
Dr. Roey Tzezana is a futures studies researcher at Tel Aviv University and a research fellow at Brown University. He’s acting as a scientific consultant to several firms and international bodies, board member at Rhode Island Israel Collaborative, and is the author of best-selling books about the future of technology and society. He has co-founded the SimPolitix project for political forecasting and TeleBuddy – a firm that operates telepresence robots around the globe, allowing him to teach, lecture and live in three different continents at the same time, using robotic avatars as his bodies. His research has led him to journey worldwide – from Kazakhstan to Latin America and even Antarctica (where he became one of the few people in the world to capture pokemon on that barren continent) – trying to understanding how technology will impact humanity and reshape our society and institutions.
Zevik is a postdoc at the Ludwig Institute and the Department of Cellular and Molecular medicine at UCSD. Zevik did is direct-PhD track in human genetics and biochemistry at Prof. Gil Ast laboratory, Tel-Aviv University, where he studied regulation of RNA splicing and miRNA biogenesis. He then moved to the laboratory of Prof. Don Cleveland in UCSD to apply his knowledge of RNA biology into neurodegenerative diseases. More specifically, he is focusing on the link between altered RNA metabolism and neurodegeneration in the devastating neurological disease Amyotrophic Lateral Sclerosis (ALS). Zevik is married +2, and he loves being near or in the ocean at any free time.
Noga loves all things that spark creativity and create some positive impact – including Art, Travel, and Science!
She joined Postdoctoral life in 2017 at Stanford (Prof. Lawrence Steinman) where she started a new chapter of her science career dedicated to neuroimmunology after completing her Ph.D. (and MSc) in regenerative immunology in the field of Bone Marrow Transplantation at the Weizmann Institute of Science (Prof. Yair Reisner).
Her husband (Shahar), their cat (Luli) and her currently reside in an overpriced apartment in Menlo Park, trying to live up to their own version of the American Dream.
Noga loves teaching and volunteering and was previously part of youth movements, Davidson Institute and Paamonim NGO in Israel. In the USA she volunteers with Women in Science, JCC, a homeless shelter/food distribution and now Science Abroad.
In her spare time, Noga is a jewelry designer, sculptor, dancer and somewhat of a travel addict.
Ziv a postdoctoral fellow in the Program in Cell Biology at The Hospital for Sick Children in Toronto, in the laboratory of Prof. Sergio Grinstein. His research is focused on macrophages, cells that are part of the innate-immune system and specialized in phagocytosis. More specifically, he studies the molecular basis of macrophage polarization to inflammatory and anti-inflammatory cells. He did his Masters and PhD in Ben-Gurion University of the Negev in the department of Life Sciences under the joint supervision of Prof. Amir Sagi and Dr. Isam Khalaila from the Department of Biotechnology Engineering. During his PhD, he studied the interaction between vitellogenin, the precursor of the main yolk protein, and its receptor in the oocytes of fresh water prawns. In 2013, he started his first postdoc in the lab of Dr. Eyal Gur in the Department of Life Sciences and The National Institute for Biotechnology in the Negev. In the Gur lab, he studied a unique mycobacterial protein degradation system, analogues to ubiquitin, in-order to develop a novel anti-tuberculosis antibiotics.
His free time is dedicated to his family, his beloved wife Nirit and their two adorable girls, Shai and Sheer. Together they explore the great Canadian wild and the local music scene
Ranen received his BSc (2008) and PhD (2014) in molecular biology from Tel Aviv University, studying mechanisms that regulate protein synthesis during cancer cell division. In 2015 he moved to San Francisco, CA, to start his postdoctoral training at UCSF and Stanford, supported by EMBO and Human Frontier long-term fellowships. Current research interests include proteomic characterization of virus-host interactions in Zika and Dengue viruses, as well as development of novel methods for studying such interactions.
Ron is a postdoctoral fellow in the Molecular Biophysics and Biochemistry Department at Yale University. He joined the lab of Prof. Jonathon Howard in 2015 to explore and to learn about the world of motor proteins and cytoskeleton. He received his Ph.D. from the Hebrew University of Jerusalem in the Organic Chemistry Department under the supervision of Prof. Itamar Willner.
Prior to that, he received his M.Sc. from Tel-Aviv University in the Department of Molecular Microbiology & Biotechnology under the supervision of Prof. Ehud Gazit.
Ron is married to Meital and they have two children, Alon and Maya. He joined ScienceAbroad in order to establish an Israeli community at Yale.
Liron holds a Ph.D. in neuroscience from Tel-Aviv University, where her primary research focus was negative symptoms of schizophrenia. She investigated deep Transcrainial Magnetic Stimulation for the treatment of negative symptoms, as well as examined the symptoms structure and leading assessment tools for negative symptoms and depression in schizophrenia.
In her post-doctoral work, conducted at the Olin Neuropsychiatry Research Center, she focuses on brain circuitry and dynamics, in schizophrenia, autism spectrum disorder, anxiety disorders and additional psychiatric conditions, as well as healthy individuals.